EP Patent

EP4457219A4 — Solid forms of 1-{3-[3-(4-chlorophenyl)propoxypropyl} piperidine hydrochloride and methods for its preparation

Assigned to Biophore India Pharmaceuticals Pvt Ltd · Expires 2025-12-10 · 0y expired

What this patent protects

Patent listed against pitolisant-hydrochloride.

Drugs covered by this patent

pitolisant-hydrochloride (PITOLISANT HYDROCHLORIDE)

Patent Metadata

Patent number: EP4457219A4
Jurisdiction: EP
Classification: —
Expires: 2025-12-10
Drug substance claim: No
Drug product claim: No
Assignee: Biophore India Pharmaceuticals Pvt Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.